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Background: Patients with chronic kidney disease (CKD) have worse cardiovascular outcomes than those without CKD. Individuals with a negative 
stress myocardial perfusion imaging (MPS) with technetium-99m tracers study have very low rates of cardiac events. Although small cohorts of 
patients with CKD on normal MPS have demonstrated that event rates are likely low, it is uncertain whether subsets of these patients are at 
increased risk, even in the presence of a normal scan. The purpose of this work was to determine the characteristics of the patients with CKD and 
normal MPS who had cardiac events during follow-up.
Methods and Results: We followed up 823 consecutive patients who underwent stress MPS for cardiac events for 3 years. 312 pts had a 
summed stress score of <or=3, which was considered normal. The prevalence rate of CKD (eGFR<60, Stages 3-5) was 33.7% (n=105) in normal 
MPS patients, 52% (n=54) in those with CKD Stage 3, 37% (n=39) in those with CKD Stage 4, and 11% (n=12) in those with CKD Stages 5. Patients 
with normal MPS and CKD had higher unadjusted annual cardiac event rates than those with no CKD and normal MPS (2.5% versus 0.8%, P<0.05). 
Backgrounds of CKD patients with normal MPS were analyzed in cardiac event or non-event subgroups. There were no significant differences in any 
baseline clinical parameters between the two groups. The rate of loss of eGFR was significantly higher in the event group compared with non-event 
subjects (P < 0.05). The observed decline rate in eGFR during the study was 5.93 ml/min per 1.73 m2 per year in the event group compared with 
1.88 ml/min per 1.73 m2 per year in the non-event group.
Conclusions: The patients with cardiac event who had normal MPS and CKD were significantly more likely to experience rapid progression of renal 
dysfunction. Management of renal function is prognostically important even in the CKD patients with negative stress MPS.
